Recombinant human erythropoietin - Uni-Bio Science GroupAlternative Names: rhEPO-Fc
Latest Information Update: 05 Jan 2016
At a glance
- Originator Uni-Bio Science Group
- Class Antianaemics; Recombinant erythropoietins; Recombinant fusion proteins
- Mechanism of Action Erythropoiesis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Anaemia
Most Recent Events
- 01 Jun 2015 Phase-I clinical trials in Anaemia in China (unspecified route)